Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy

Prescription and non-prescription medications are frequently used by women of childbearing age. As many as 40 to 80 percent of women receive at least one prescription drug during pregnancy. It is essential to understand the potential teratogenicity of medications and offer pregnant women appropriate...

Full description

Saved in:
Bibliographic Details
Published in:Dermatology online journal 2012-10, Vol.18 (10), p.15-15
Main Authors: Wong, Jillian W, Heller, Misha M, Murase, Jenny E
Format: Article
Language:English
Subjects:
Abnormalities, Drug-Induced - prevention & control
Dermatologic Agents - classification
Dermatologic Agents - therapeutic use
Evidence-Based Medicine
Female
Fetus - drug effects
Humans
Pregnancy
Pregnancy Complications - drug therapy
Risk Assessment
United States
United States Food and Drug Administration
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prescription and non-prescription medications are frequently used by women of childbearing age. As many as 40 to 80 percent of women receive at least one prescription drug during pregnancy. It is essential to understand the potential teratogenicity of medications and offer pregnant women appropriate counseling. Available classification references include the Swedish Catalogue of Approved Drugs, the US Food and Drug Administration, the Australian system, and the Evidence-Based Medicine system.
ISSN:1087-2108
1087-2108
DOI:10.5070/D34RT8H47W